Randomized Placebo Control Study of Metformin in Psoriasis Patients with Metabolic Syndrome (Systemic Treatment Cohort)

BACKGROUND: Psoriasis has been found to be associated with obesity, metabolic syndrome (MS), diabetes, and cardiovascular risk factors. Metformin treatment showed improvement in cardiovascular risk factors and hyperinsulinemia. OBJECTIVE: To evaluate the efficacy and safety of metformin in psoriasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Surjit, Bhansali, Anil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477448/
https://www.ncbi.nlm.nih.gov/pubmed/28670544
http://dx.doi.org/10.4103/ijem.IJEM_46_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477448/
https://www.ncbi.nlm.nih.gov/pubmed/28670544
http://dx.doi.org/10.4103/ijem.IJEM_46_17

Ejemplares similares